Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Ledingham

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Pharmacology & Physiology|July 20, 2000
Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalaprilJ M Ledingham, R Laverty
The Journal of Physiology|September 1, 1970
Haemodynamic and other studies in the renoprival hypertensive ratJ M Ledingham, D Pelling
Clinical Science|February 1, 1971
Circulatory changes in experimental hypertensionJ M Ledingham, D Pelling
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strainJ M Ledingham, R Laverty
Journal of Hypertension|January 14, 1999
Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodellingJ M Ledingham, R Laverty
Clinical and Experimental Pharmacology & Physiology|September 19, 2001
Effects of nitric oxide synthase inhibition and low-salt diet on blood pressure and mesenteric resistance artery remodelling in genetically hypertensive ratsJ M Ledingham, R Laverty
Clinical Science|January 1, 1970
Haemodynamics in the renoprival hypertensive ratD Pelling, J M Ledingham
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonistJ M Ledingham, R Laverty
Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1995
Long-term effects of treatment with enalapril on the structure of mesenteric resistance arteries in New Zealand genetically hypertensive ratsJ M Ledingham, R Laverty
Clinical Science and Molecular Medicine|January 1, 1974
Proceedings: Pressor sensitivity to angiotensin II in relation to sodiumB Slack, J M Ledingham
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Pharmacology & Physiology|July 20, 2000
Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalaprilJ M Ledingham, R Laverty
The Journal of Physiology|September 1, 1970
Haemodynamic and other studies in the renoprival hypertensive ratJ M Ledingham, D Pelling
Clinical Science|February 1, 1971
Circulatory changes in experimental hypertensionJ M Ledingham, D Pelling
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strainJ M Ledingham, R Laverty
Journal of Hypertension|January 14, 1999
Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodellingJ M Ledingham, R Laverty
Clinical and Experimental Pharmacology & Physiology|September 19, 2001
Effects of nitric oxide synthase inhibition and low-salt diet on blood pressure and mesenteric resistance artery remodelling in genetically hypertensive ratsJ M Ledingham, R Laverty
Clinical Science|January 1, 1970
Haemodynamics in the renoprival hypertensive ratD Pelling, J M Ledingham
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonistJ M Ledingham, R Laverty
Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1995
Long-term effects of treatment with enalapril on the structure of mesenteric resistance arteries in New Zealand genetically hypertensive ratsJ M Ledingham, R Laverty
Clinical Science and Molecular Medicine|January 1, 1974
Proceedings: Pressor sensitivity to angiotensin II in relation to sodiumB Slack, J M Ledingham
Pageof 7